[1]
|
Ozen S. Update in familial Mediterranean fever[J]. Curr Opin Rheumatol, 2021, 33:398-402. |
[2]
|
Bhatt H, Cascella M. Familial Mediterranean Fever[M]. In StatPearls, StatPearls Publishing, 2022. |
[3]
|
Shinar Y, Ceccherini I, Rowczenio D, et al. ISSAID/EMQN Best practice guidelines for the genetic diagnosis of Monognenic AIDs in the next generaion sequencing era[J]. Clin Chem, 2020, 66:525-536. |
[4]
|
Gedalia A, Zamir S. Neurologic manifestations in familial Mediterranean fever[J]. Pediatr Neurol, 1993, 9:301-302. |
[5]
|
Ertekin V, Selimoglu MA, Pirim I. Familial Mediterranean fever in a childhood population in eastern Turkey[J]. Pediatr Int, 2005, 47:640-644. |
[6]
|
Canpolat M, Gumus H, Gunduz Z, et al. Neurological Manifestations in Familial Mediterranean Fever:Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey[J]. Neuropediatrics, 2017, 48:79-85. |
[7]
|
Canpolat M, Kumandas S, Poyrazoglu HG, et al. Prevalence and risk factors of epilepsy among school children in Kayseri City Center, an urban area in Central Anatolia, Turkey[J]. Seizure, 2014, 23:708-716. |
[8]
|
Salehzadeh F, Azami A, Motezarre M, et al. Neurological Manifestations in Familial Mediterranean Fever:a Genotype-Phenotype Correlation Study[J]. Open Access Rheumatol, 2020, 12:15-19. |
[9]
|
World Health Organization. Epilepsy in the WHO Eastern Mediterranean region:bridging the gap[EB/M].[2022-03-01].https://apps.who.int/iris/handle/10665/119905. |
[10]
|
Çomak E, Tüfekçi Ö, Kılıçbay F, et al. Febrile seizures in children with familial Mediterranean fever:Coincidence or association?[J]. Eur J Paediatr Neurol, 2015, 19:572-576. |
[11]
|
Carman KB, Ekici A, Yimenicioglu S, et al. The prevalence of febrile seizure and associated factors among Turkish children[J]. Int J Clin Pediatr, 2014, 3:1-4. |
[12]
|
Okan N, Okan M, Eralp O, et al. The prevalence of neurological disorders among children in Gemlik (Turkey)[J]. Dev Med Child Neurol, 1995, 37:597-603. |
[13]
|
Yakinci C, Kutlu NO, Durmaz Y, et al. Prevalence of febrile convulsion in 3637 children of primary school age in the province of Malatya[J]. Turk J Trop Pediatr, 2000, 46:249-250. |
[14]
|
Özen F, Kocak N, Kelekci S, et al. The prevalence of Familial Mediterranean Fever common gene mutations in patients with simple febrile seizures[J]. Eur Rev Med Pharmacol Sci, 2014, 18:657-660. |
[15]
|
Biro O, Gileles-Hillel A, Dor-Wollman T, et al. Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings[J].Eur J Pediatr, 2022, 181:973-978. |
[16]
|
Akman-Demir G, Gul A, Gurol E, et al. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF):coincidence or association?[J] J Neurol, 2006, 253:928-934. |
[17]
|
Unal A, Dursun A, Emre U, et al. Evaluation of common mutations in the Mediterranean fever gene in Multiple Sclerosis patients:is it a susceptibility gene?[J]. J Neurol Sci, 2010, 294:38-42. |
[18]
|
Shinar Y, Livneh A, Villa Y, et al. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients[J].Genes Immun, 2003, 4:197-203. |
[19]
|
Kalyoncu U, Eker A, Oguz KK, et al. Familial Mediterranean fever and central nervous system involvement:a case series[J]. Medicine, 2010, 89:75-84. |
[20]
|
Yahalom G, Kivity S, Lidar M, et al. Familial Mediterranean fever (FMF) and multiple sclerosis:an association study in one of the world's largest FMF cohorts[J]. Eur J Neurol, 2011, 18:1146-1150. |
[21]
|
Furlan R, Filippi M, Bergami A, et al. Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study[J]. J Neurol Neurosurg Psychiatry, 1999, 67:785-788. |
[22]
|
Elhani I, Dumont A, Vergneault H, et al. Association between familial Mediterranean fever and multiple sclerosis:A case series from the JIR cohort and systematic literature review[J].Mult Scler Relat Disord, 2021, 50:102834. |
[23]
|
Gedalia A, Zamir S. Neurologic manifestations in familial Mediterranean fever[J]. Pediatr Neurol, 1993, 9:301-302. |
[24]
|
Karachaliou I, Karachalios G, Charalabopoulos A, et al. Meningitis associated with familial Mediterranean fever[J]. Int J Clin Pract Suppl, 2005, 147:60-61. |
[25]
|
Schwabe AD, Monroe JB. Meningitis in familial Mediterranean fever[J]. Am J Med, 1988, 85:715-717. |
[26]
|
Barakat MH, Mustafa HT, Shakir RA. Mollaret's meningitis. A variant of recurrent hereditary polyserositis, both provoked by metaraminol[J]. Arch Neurol, 1988, 45:926-927. |
[27]
|
Feld O, Yahalom G, Livneh A. Neurologic and other systemic manifestations in FMF:published and own experience[J]. Best Pract Res Clin Rheumatol, 2012, 26:119-133. |
[28]
|
李栋方,唐文婷,邱坤银,等.一个常染色体显性遗传型地中海热家系的临床及遗传学分析[J].中华医学遗传学杂志, 2021, 38:719-722. |
[29]
|
Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension[J]. Neurology, 2002, 59:1492. |
[30]
|
Gökalp HZ, Başkaya MK, Aydin V. Pseudotumor cerebri with familial Mediterranean fever[J]. Clin Neurol Neurosurg, 1992, 94:261-263. |
[31]
|
Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome[J]. J Neurol, 2017, 264:1608-1616. |
[32]
|
Aksoy DY, Arici M, Kiykim AA, et al. Posterior leukoencephalopathy and nephrotic syndrome:just a coincidence?[J]. Am J Med Sci, 2004, 327:156-159. |
[33]
|
Bartynski WS. Posterior reversible encephalopathy syndrome, part 2:controversies surrounding pathophysiology of vasogenic edema[J]. AJNR Am J Neuroradiol, 2008, 29:1043-1049. |
[34]
|
Ulaşlı AM, Kutlu G, Kocatürk Ö, et al. Posterior reversible encephalopathy during an attack of familial Mediterranean fever[J]. Rheumatol Int, 2012, 32:1779-1781. |
[35]
|
Abbara S, Grateau G, Ducharme-Bénard S, et al. Association of Vasculitis and Familial Mediterranean Fever[J]. Front Immunol, 2019, 10:763. |
[36]
|
Nussinovitch U, Volovitz B, Nussinovitch M, et al. Abnormal heart rate variability in AA amyloidosis of familial Mediterranean fever[J]. Amyloid, 2011, 18:206-210. |
[37]
|
Lavi E, Maree A, Eisenstein EM, et al. Increased prevalence of attention-deficit hyperactivity disorder symptomatology in patients with familial Mediterranean fever[J].Mod Rheumatol, 2022, 32:422-426. |
[38]
|
Biro O, Gileles-Hillel A, Dor-Wollman T, et al. Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings[J].Eur J Pediatr, 2022, 181:973-978. |
[39]
|
Wilbur K, Makowsky M. Colchicine myotoxicity:case reports and literature review[J]. Pharmacotherapy, 2004, 24:1784-1792. |
[40]
|
Ben-Chetrit E, Backenroth R.Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene[J]. Ann Rheum Dis, 2001, 60:146-149. |